2025

  • Dr. Dickey published a paper titled: "Antimicrobial peptide class that forms discrete β-barrel stable pores anchored by transmembrane helices" was published in the journal Nature Communications https://www.nature.com/articles/s41467-025-62604-1
  • Nelson, D.C. & Shen, Y. Streptococci/epithelial cell coculture assay.
    Bio-protocol. 2025 (doi: bio-protocol.org/prep2821)
    Castallanos, G., Gonzalez-Juarbe, N., & Nelson, D.C. Endolysins: targeting Streptococcus pneumoniae in its major anatomical niches of infection and addressing the hurdles.
    Front. Microbiol. 16:1660791, 2025. (doi: 10.3389/fmicb.2025.1660791)
  • N. Wang, Y., Stevens, M.T., Wang, T., Alreja, A.B., Nelson, D.C. Britton, W.J., & Chan, H-K. Efficacy of inhalable endolysin Cpl-1 formulations in combination with gentamycin or endolysin Pal in a murine lung infection model.
    Pharm. Res. 2026. (doi: 10.1007/s11095-025-03942-z)

2024

  • Dr. Zhang published a paper titled: "Langat virus inhibits the gp130/JAK/STAT signaling by reducing the gp130 protein level" was published in the Journal of Medical Virology 2024 https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.29522
  • Dr. Nelson published a paper titled: “Bacteriophage endolysin treatment for systemic infection of Streptococcus iniae in hybrid striped bass” was published in the Fish and Shellfish Immunology Journal. https://www.sciencedirect.com/science/article/pii/S1050464823007829.
  • Deshotel, M.B., Dave, U.M., Farmer, B., Kemboi, D., & Nelson, D.C. Bacteriophage endolysin treatment for systemic infection of Streptococcus iniae in hybrid striped bass.  
    Fish Shellfish Immunol. 145:109296, 2024 (doi: 10.1016/j.fsi.2023.109296)
    Alreja, A.B., Appel, A.E., Zhu, J.C., Riley, S.P, Gonzalez-Juarbe, N. & Nelson, D.C. SP-CHAP, an endolysin with enhanced activity against biofilm pneumococci and nasopharyngeal colonization.
    mBio. 15:e00069-24, 2024 (doi: 10.1128/mbio.00069-24)
  • Nelson, D.C., Dave, U.M., & Gonzalez-Juarbe, N. Harnessing mRNA to unleash endolysins: A new frontier in antibacterial therapy.
    Mol. Ther. Nucleic Acids. 35:102249, 2024 (doi: 10.1016/j.omtn.2024.10224